ARNOLD C HANISH

CIK 1233253 · Chief Accounting Officer · last filed 2026-01-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.84M

Companies

3

Total Filings

49

Lifetime Open-Market Net

-$331.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Salarius Pharmaceuticals, Inc. (SLRX) Delisted Director 5,000 $0.84 $4.2K $65.2K 18 2026-01-02
OMER Director 17,400 $8.73 $152.0K -$21.1K 17 2025-07-01
LLY Chief Accounting Officer 26,201 $1133.00 $29.69M -$375.5K 14 2012-10-30

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-01-27 LLY Grant (A) +3,415 $118.6K EDGAR
2010-01-28 LLY Grant (A) +3,378 $122.1K EDGAR
2009-11-23 LLY Mixed −2,860 -$98.0K EDGAR
2009-04-29 LLY Tax (F) −463 -$15.3K EDGAR
2009-01-29 LLY Grant (A) +1,636 $63.2K EDGAR
2008-01-29 LLY Grant (A) +2,579 $130.9K EDGAR
2007-05-03 LLY Mixed −1,690 -$92.9K EDGAR
2007-05-01 LLY Tax (F) −463 -$27.7K EDGAR
2007-01-19 LLY Grant (A) +1,295 $68.5K EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.